These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Long-term effect of human mini-dystrophin in transgenic mdx mice improves muscle physiological function. Chu X; Li J; Qiao C; Wang J; Wang Y; Jiang XC; You H; Xiao X; Wang B FASEB J; 2021 Jun; 35(6):e21628. PubMed ID: 33982338 [TBL] [Abstract][Full Text] [Related]
23. Effects of prednisolone on the dystrophin-associated proteins in the blood-brain barrier and skeletal muscle of dystrophic mdx mice. Tamma R; Annese T; Capogrosso RF; Cozzoli A; Benagiano V; Sblendorio V; Ruggieri S; Crivellato E; Specchia G; Ribatti D; De Luca A; Nico B Lab Invest; 2013 May; 93(5):592-610. PubMed ID: 23528847 [TBL] [Abstract][Full Text] [Related]
24. Effects of fish oil containing eicosapentaenoic acid and docosahexaenoic acid on dystrophic mdx mice. Fogagnolo Mauricio A; Minatel E; Santo Neto H; Marques MJ Clin Nutr; 2013 Aug; 32(4):636-42. PubMed ID: 23218947 [TBL] [Abstract][Full Text] [Related]
26. Weekly oral prednisolone improves survival and strength in male mdx mice. Keeling RM; Golumbek PT; Streif EM; Connolly AM Muscle Nerve; 2007 Jan; 35(1):43-8. PubMed ID: 16969833 [TBL] [Abstract][Full Text] [Related]
27. Doxycycline ameliorates the dystrophic phenotype of skeletal and cardiac muscles in mdx mice. Pereira JA; Taniguti AP; Matsumura C; Marques MJ; Neto HS Muscle Nerve; 2012 Sep; 46(3):400-6. PubMed ID: 22907231 [TBL] [Abstract][Full Text] [Related]
28. Functional substitution by TAT-utrophin in dystrophin-deficient mice. Sonnemann KJ; Heun-Johnson H; Turner AJ; Baltgalvis KA; Lowe DA; Ervasti JM PLoS Med; 2009 May; 6(5):e1000083. PubMed ID: 19478831 [TBL] [Abstract][Full Text] [Related]
29. Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice. Messina S; Bitto A; Aguennouz M; Minutoli L; Monici MC; Altavilla D; Squadrito F; Vita G Exp Neurol; 2006 Mar; 198(1):234-41. PubMed ID: 16410003 [TBL] [Abstract][Full Text] [Related]
30. Long-term clenbuterol administration alters the isometric contractile properties of skeletal muscle from normal and dystrophin-deficient mdx mice. Hayes A; Williams DA Clin Exp Pharmacol Physiol; 1994 Oct; 21(10):757-65. PubMed ID: 7867226 [TBL] [Abstract][Full Text] [Related]
31. Total Absence of Dystrophin Expression Exacerbates Ectopic Myofiber Calcification and Fibrosis and Alters Macrophage Infiltration Patterns. Young CNJ; Gosselin MRF; Rumney R; Oksiejuk A; Chira N; Bozycki L; Matryba P; Łukasiewicz K; Kao AP; Dunlop J; Robson SC; Zabłocki K; Górecki DC Am J Pathol; 2020 Jan; 190(1):190-205. PubMed ID: 31726040 [TBL] [Abstract][Full Text] [Related]
32. Dystrophic mdx mice develop severe cardiac and respiratory dysfunction following genetic ablation of the anti-inflammatory cytokine IL-10. Nitahara-Kasahara Y; Hayashita-Kinoh H; Chiyo T; Nishiyama A; Okada H; Takeda S; Okada T Hum Mol Genet; 2014 Aug; 23(15):3990-4000. PubMed ID: 24659498 [TBL] [Abstract][Full Text] [Related]
33. Strength and corticosteroid responsiveness of mdx mice is unchanged by RAG2 gene knockout. Golumbek PT; Keeling RM; Connolly AM Neuromuscul Disord; 2007 May; 17(5):376-84. PubMed ID: 17452104 [TBL] [Abstract][Full Text] [Related]
34. Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice. Schertzer JD; Ryall JG; Lynch GS Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E499-505. PubMed ID: 16621899 [TBL] [Abstract][Full Text] [Related]
37. Is the normal content of sulfhydryl groups attributable to sparing from dystrophic pathology in dystrophin-deficient muscles? Niebrój-Dobosz I; Fidziańska A; Glinka Z; Hausmanowa-Petrusewicz I Folia Neuropathol; 2002; 40(3):143-50. PubMed ID: 12572920 [TBL] [Abstract][Full Text] [Related]
38. IGF-II ameliorates the dystrophic phenotype and coordinately down-regulates programmed cell death. Smith J; Goldsmith C; Ward A; LeDieu R Cell Death Differ; 2000 Nov; 7(11):1109-18. PubMed ID: 11139285 [TBL] [Abstract][Full Text] [Related]
39. Steroids in Duchenne muscular dystrophy: from clinical trials to genomic research. Muntoni F; Fisher I; Morgan JE; Abraham D Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S162-5. PubMed ID: 12206811 [TBL] [Abstract][Full Text] [Related]
40. Unacylated Ghrelin Enhances Satellite Cell Function and Relieves the Dystrophic Phenotype in Duchenne Muscular Dystrophy mdx Model. Reano S; Angelino E; Ferrara M; Malacarne V; Sustova H; Sabry O; Agosti E; Clerici S; Ruozi G; Zentilin L; Prodam F; Geuna S; Giacca M; Graziani A; Filigheddu N Stem Cells; 2017 Jul; 35(7):1733-1746. PubMed ID: 28436144 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]